Abstract:A nano photoimmunotherapy system is fabricated that can promote rapid pyroptosis and modify the inflammatory microenvironment. The treatments between immunodeficient mice and normal mice prove that pyroptosis of cancer cells can better facilitate immune cell infiltration and then obtain tumor suppression, which provide the potential to address the problem of checkpoint‐inhibitor immunotherapy inefficacy in immune‐suppressed cold tumor care field. Immunotherapy, especially immune checkpoint blockade (ICB) antibody immunotherapy, has revolutionized the treatment ways of cancers and provided remarkable clinical benefits for multiple cancers. However, the efficacy of immunotherapy in tumors with an immune‐excluded or immune‐suppressed phenotype is dismal due to the lack or paucity of immune infiltration in the tumor microenvironment. Herein, an emerging photoimmunotherapy based on remodeling the inflammatory microenvironment is reported, ascribed to nanoagonist‐mediated gasdermin E (GSDME)‐dependent pyroptosis and providing positive feedback to activate anti‐PD‐1 immunotherapy. An iridium‐based photosensitizer (IrP) carrying methyltransferase inhibitor RG108 (R@IrP) lead to rapid cell pyroptosis via the caspase‐3/GSDME pathway under the light activation. Furthermore, light‐elicited pyroptosis synergized with anti‐PD‐1 to induce anti‐tumor photoimmunotherapy. The pro‐inflammatory factors released by pyroptotic cells remodel the inflammatory microenvironment and recruit immune cells to kill tumor cells, resulting in CD8+ cytotoxic T lymphocytes activation, PD‐1 expression enhancement, and dendritic cell slightly maturation. Collectively, these findings present a synergistic strategy of photoimmunotherapy, that is, turning immunological cold tumors into hot tumors that can respond to anti‐PD‐1‐based immunotherapy via precise pathway regulation.

Endogenous/exogenous stimulies inspired polyprodrug nano-inducer switches pyroptosis path for promoting antitumor immunity

Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy

Dual-stimulus phototherapeutic nanogel for triggering pyroptosis to promote cancer immunotherapy.

Immunomodulatory‐Photodynamic Nano‐Stimulators for Invoking Pyroptosis to Augment Tumor Immunotherapy

Hypoxia-accelerating pyroptosis nanoinducers for promoting image-guided cancer immunotherapy

Simultaneous Activation of Pyroptosis and cGAS‐STING Pathway with Epigenetic/ Photodynamic Nanotheranostic for Enhanced Tumor Photoimmunotherapy

Engineering Prodrug Nanomicelles As Pyroptosis Inducer for Codelivery of PI3K/mTOR and CDK Inhibitors to Enhance Antitumor Immunity.

Nanoagonist‐Mediated GSDME‐Dependent Pyroptosis Remodels the Inflammatory Microenvironment for Tumor Photoimmunotherapy

Multi‐Enzyme Nanoparticles as Efficient Pyroptosis and Immunogenic Cell Death Inducers for Cancer Immunotherapy

Reactive Oxygen Species‐Mediated Pyroptosis with the Help of Nanotechnology: Prospects for Cancer Therapy

Inspired heat shock protein alleviating prodrug enforces immunogenic photodynamic therapy by eliciting pyroptosis

Pyroptosis Induction Synergized with IDO Inhibition of Ternary Biomedicine for Photodynamic Activated Tumor Immunotherapy

Laser boosting the influx of calcium ions to enhance gasdermin e-dependent pyroptosis driven by a dual-layer polydopamine nanoagonist

Near‐Infrared Light Triggered Thermoresponsive Pyroptosis System for Synergistic Tumor Immunotherapy

Biomimetic Nanoparticle Synchronizing Pyroptosis Induction and Mitophagy Inhibition for Anti-Tumor Therapy.

A pyroptosis nanotuner for cancer therapy

Programmed Cascade Polydopamine Nanoclusters for Pyroptosis‐Based Tumor Immunotherapy

Biodegradable Ca2+ Nanomodulators Activate Pyroptosis Through Mitochondrial Ca2+ Overload for Cancer Immunotherapy

Biomimetic Nano‐Photosensitizer Amplifies Immunogenic Pyroptosis and Triggers Synergistic Cancer Therapy

Biodegradable pyroptosis inducer with multienzyme-mimic activity kicks up reactive oxygen species storm for sensitizing immunotherapy

Boarding pyroptosis onto nanotechnology for cancer therapy